XML 65 R34.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisition and Stockholders' Equity (Deficit) (Details 3) (USD $)
In Thousands, unless otherwise specified
12 Months Ended 0 Months Ended
Dec. 31, 2013
Jan. 17, 2013
Liabilities    
Recapitalization of Synergy $ (4,904)sgyp_AdjustmentsToAdditionalPaidInCapitalRelatedPartyMerger  
Callisto    
Assets    
Security deposits   74sgyp_BusinessAcquisitionPurchasePriceAllocationSecurityDeposits
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember
Total assets acquired   74us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember
Liabilities    
Accounts payable and other liabilities   (1,400)sgyp_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndOtherLiabilities
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember
Net liabilities assumed in excess of assets acquired   (1,326)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember
Elimination of amounts due from Callisto   (3,578)sgyp_DebtEliminationRelatedParty
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember
Recapitalization of Synergy   $ (4,904)sgyp_AdjustmentsToAdditionalPaidInCapitalRelatedPartyMerger
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember